Euro heart score sheet to calculate risk score for patients presenting with stable angina (derived from 3779 patients with newly diagnosed SIHD). *$1 of previous cerebrovascular event; hepatic disease defined as chronic hepatitis or cirrhosis, or other hepatic disease causing elevation of transaminases $3 times upper limit of normal; PVD defined as claudication either at rest or on exertion, amputation for arterial vascular insufficiency, vascular surgery (reconstruction or bypass) or angioplasty to the extremities, documented aortic aneurysm, or noninvasive evidence of impaired arterial flow; chronic renal failure defined as chronic dialysis or renal transplantation or serum creatinine .200 mmol/L; chronic respiratory disease defined as a diagnosis previously made by physician or patient receiving bronchodilators or FEV1 ,75%, arterial PO2 ,60%, or arterial PCO2 .50% predicted in previous studies; chronic inflammatory conditions defined as a diagnosis of rheumatoid arthritis, systemic lupus erythematosus or other connective tissue dis- ease, polymyalgia rheumatica, and so on; malignancy defined as a diagnosis of malignancy within a year of active malignancy. FEV1 indicates forced expiratory volume; PO2, partial pressure of oxygen; PCO2, partial pressure of carbon dioxide; and PVD, peripheral vas- cular disease. Reproduced from Daly et al.57 Figure 10. Risk of death or MI over 1 year after diagnosis of SIHD according to Euro heart score. Plot to assign estimated probability of death or nonfatal MI within 1 year of presentation according to combination of clinical and investigative features in patients with stable angina. MI indicates myocardial infarction. Reproduced from Daly et al.57 Figure 11. Nomogram showing the probability of severe (3-vessel or left main) coronary disease based on a 5-point score. One point is awarded for each of the following variables: male sex, typical angina, history and electrocardiographic evi- dence of MI, and diabetes mellitus and use of insulin. 